Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 751 AL 765

The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

Huang C, Wei Z, Zheng N, Yan J, Zhang J, Ye X, Zhao W.

Alzheimers Dement. 2025 Feb;21(2):e14618. doi: 10.1002/alz.14618.

Promising Natural Remedies for Alzheimer's Disease Therapy

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2025 Feb 17;30(4):922. doi: 10.3390/molecules30040922.

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes

Ramakrishan P, Rajangam J, Mahinoor SS, Bisht S, Mekala S, Upadhyay DK, Solomon VR, Sabarees G, Pelluri R.

Metab Brain Dis. 2025 Feb 26;40(3):132. doi: 10.1007/s11011-025-01555-4.

Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease

Kaur V, Sunkaria A.

Behav Brain Res. 2025 Apr 27;484:115505. doi: 10.1016/j.bbr.2025.115505. Epub 2025 Feb 25.

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer's Disease

Naik RA, Mir MN, Malik IA, Bhardwaj R, Alshabrmi FM, Mahmoud MA, Alhomrani M, Alamri AS, Alsanie WF, Hjazi A, Ghatak T, Poeggeler B, Singh MP, Ts G, Singh SK.

Front Biosci (Landmark Ed). 2025 Feb 18;30(2):25551. doi: 10.31083/FBL25551.

Cognitive resilience in Alzheimer's disease: Mechanism and potential clinical intervention

Jia B, Xu Y, Zhu X.

Ageing Res Rev. 2025 Apr;106:102711. doi: 10.1016/j.arr.2025.102711. Epub 2025 Feb 26.

The Peripheral Amyloid-β Nexus: Connecting Alzheimer's Disease with Atherosclerosis through Shared Pathophysiological Mechanisms

Khowdiary MM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhenawy AA, Rashwan EK, Alexiou A, Papadakis M, Fetoh MEA, Batiha GE.

Neuromolecular Med. 2025 Mar 3;27(1):20. doi: 10.1007/s12017-025-08836-2.

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.

[Neurobiological potential of astragaloside IV and prospects for its use in the treatment of Alzheimer's disease]

Berezutsky MA, Durnova NA, Kurchatova MN, Matvienko UA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(2):7-12. doi: 10.17116/jnevro20251250217.

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective

Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SAW.

Br J Clin Pharmacol. 2025 May;91(5):1352-1360. doi: 10.1002/bcp.70021. Epub 2025 Mar 6.

Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease

Mesias A, Borges S, Pintado M, Baptista-Silva S.

Neuropeptides. 2025 Jun;111:102515. doi: 10.1016/j.npep.2025.102515. Epub 2025 Mar 4.

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

Dahiya M, Yadav M, Goyal C, Kumar A.

Inflammopharmacology. 2025 Apr;33(4):1817-1831. doi: 10.1007/s10787-025-01704-2. Epub 2025 Mar 10.

Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer's Disease-Are There Connections?

Fułek M, Hachiya N, Gachowska M, Beszłej JA, Bartoszewska E, Kurpas D, Kurpiński T, Adamska H, Poręba R, Urban S, Fułek K, Leszek J.

Int J Mol Sci. 2025 Feb 27;26(5):2097. doi: 10.3390/ijms26052097.

Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review

Zaater MA, El Kerdawy AM, Mahmoud WR, Abou-Seri SM.

Int J Biol Macromol. 2025 May;307(Pt 3):142141. doi: 10.1016/j.ijbiomac.2025.142141. Epub 2025 Mar 14.

The role of n-3-derived specialised pro-resolving mediators (SPMs) in microglial mitochondrial respiration and inflammation resolution in Alzheimer's disease

Slayo M, Rummel C, Singhaarachchi PH, Feldotto M, Spencer SJ.

Mol Neurodegener. 2025 Mar 21;20(1):35. doi: 10.1186/s13024-025-00824-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias